Recently, a second patient with a clinical presentation of late-onset SMA was identified in a French family with the heterozygous p.H446Q mutation, suggesting that genetically unsolved late-onset SMA patients should be considered for MORC2 sequencing (Jacquier et al., 2022). This evidence concerns the gene MORC2 and proximal spinal muscular atrophy.